Abstract
Secondary prophylaxis of rheumatic fever recurrence with intramuscular benzylpenicillin seems to be the most widely used therapy in young Italian patients. Its duration may vary from several years to decades. Pain and subsequent discomfort related to benzylpenicillin administration are poorly detected and addressed in our country. We present here a survey in which 49 Italian families participated, with children receiving benzylpenicillin therapy every 3 to 4 weeks. Procedural pain, treatment setting, information and communication emerge as critical issues for families. The long course of treatment of these young patients needs to be more explored, reviewed, and likely reorganized, with the aim of limiting and managing, with every applicable measure, the criticality of pain and supporting proper information and communication, equally important aspects of care.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call